4//SEC Filing
THOMPSON PHILLANDAS T. 4
Accession 0001567619-19-006618
CIK 0001012477other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 7:16 PM ET
Size
15.6 KB
Accession
0001567619-19-006618
Insider Transaction Report
Form 4
THOMPSON PHILLANDAS T.
See Remarks
Transactions
- Award
Stock Option (right to buy)
2019-03-07$1.85/sh+100,000$185,000→ 100,000 totalExercise: $1.85Exp: 2029-03-07→ ADSs (100,000 underlying) - Award
ADSs
2019-03-07+18,000→ 113,671 total
Holdings
- 95,000
Stock Option (right to buy)
Exercise: $16.30Exp: 2024-12-11→ ADSs (95,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $14.35Exp: 2025-12-10→ ADSs (100,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $10.40Exp: 2026-12-14→ ADSs (100,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $7.36Exp: 2023-12-12→ ADSs (100,000 underlying) - 80,000
Stock Option (right to buy)
Exercise: $8.95Exp: 2027-12-12→ ADSs (80,000 underlying)
Footnotes (9)
- [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- [F2]Includes (a) 10,000 restricted ADSs granted under the issuer's "Free Share" award program on 12/11/2014, all of which were issued to the reporting person on the 4th anniversary of the grant date; (b) 20,000 restricted ADSs granted under the "Free Share" award program on 8/10/2016, all of which were issued to the reporting person on the 2nd anniversary of the grant date; (c) 18,000 restricted ADSs granted under the "Free Share" award program on 12/14/2016, all of which were issued to the reporting person on the 2nd anniversary of the grant date; (d) 18,000 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 12/12/2017, of which 12,000 and 6,000 ADSs will vest and be issued to the reporting person on the 2nd anniversary and 3rd anniversary, respectively, of the grant date (with such vesting subject to the reporting person remaining in continuous service until the applicable anniversary); [continued in footnote 3 below]
- [F3](e) 3,000 and 1,671 ADSs acquired under the issuer's 2017 Employee Share Purchase Plan on 7/5/2018 and 1/8/2019, respectively; and (f) 18,000 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 3/7/2019, of which 12,000 and 6,000 ADSs will vest and be issued to the reporting person on the 2nd anniversary and 3rd anniversary, respectively, of the grant date (with such vesting subject to the reporting person remaining in continuous service until the applicable anniversary).
- [F4]Options became exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/12/2013 grant date.
- [F5]Options became exercisable as to 23,750 ADSs on each of the first four anniversaries after the 12/11/2014 grant date.
- [F6]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/10/2015 grant date.
- [F7]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
- [F8]Options become exercisable as to 20,000 ADSs on each of the first four anniversaries after the 12/12/2017 grant date.
- [F9]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 3/7/2019 grant date.
Documents
Issuer
AVADEL PHARMACEUTICALS PLC
CIK 0001012477
Entity typeother
Related Parties
1- filerCIK 0001661781
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 7:16 PM ET
- Size
- 15.6 KB